Incidence and risk factors for herpes zoster in rheumatoid arthritis patients receiving upadacitinib
In this medfyle
Expert commentary by Abhijeet Danve, MD, FACP
This Medfyle was published more than two years ago. More recent Medfyle on this topic may now be available.
Acknowledgements
This is a highlights summary of an oral session given at the ACR Convergence 2020 and presented by:
Kevin Winthrop, MD, MPH
Oregon Health & Science University
Portland, OR, USA
The presenting authors of the original session had no part in the creation of this conference highlights summary.
In addition, an expert commentary on the topic has been provided by:
Abhijeet Danve, MD, FACP
Assistant Professor of Medicine
Yale University, New Haven, CT, USA
The content is produced by Infomedica, an approved ACR education partner. The summary text was drafted by Marie Farrow, and reviewed by Alessia Alunno, MD, PhD, an independent external expert, and approved by Atul Deodhar, MD, MRCP, the scientific editor of the program.
This activity is included in the ACR's Education Partner program. Independent reporting and the viewpoints expressed are those of Infomedica and its affiliates and do not represent the ACR.
About the Expert
Abhijeet Danve, MD, FACP
Assistant Professor of Medicine
Yale University, New Haven, CT, USA
Dr. Abhijeet Danve is a rheumatologist and Assistant Professor of Medicine at Yale University, New Haven, Connecticut, with a particular interest in clinical and translational research focused on early diagnosis of axial spondyloarthritis (axSpA) and management of gout. He is founding director of the spondyloarthritis program at Yale. He is member of Spondyloarthritis Research and Treatment Network (SPARTAN), and Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). Dr. Danve is a co-author on the American College Rheumatology 2020 Gout Management Guidelines.
References
1. Smitten AL, Choi HK, Hochberg MC, et al. The risk of herpes zoster in patients with rheumatoid arthritis in the United States and the United Kingdom. Arthritis Rheum 2007;57:1431–8.
2. Yun H, Yang S, Chen L, et al. Risk of Herpes Zoster in Autoimmune and Inflammatory Diseases: Implications for Vaccination. Arthritis Rheum 2016;68:2328–37.
